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Hyperoxia-induced lung structure–function 
relation, vessel rarefaction, and cardiac 
hypertrophy in an infant rat model
Francesco Greco1,2,3, Susanne Wiegert1,2,3, Philipp Baumann1,2, Sven Wellmann4, Giovanni Pellegrini5,6 
and Vincenzo Cannizzaro1,2,3* 
Abstract 
Background: Hyperoxia-induced bronchopulmonary dysplasia (BPD) models are essential for better understanding 
and impacting on long-term pulmonary, cardiovascular, and neurological sequelae of this chronic disease. Only few 
experimental studies have systematically compared structural alterations with lung function measurements.
Methods: In three separate and consecutive series, Sprague–Dawley infant rats were exposed from day of life (DOL) 
1 to 19 to either room air (0.21; controls) or to fractions of inspired oxygen  (FiO2) of 0.6, 0.8, and 1.0. Our primary 
outcome parameters were histopathologic analyses of heart, lungs, and respiratory system mechanics, assessed via 
image analysis tools and the forced oscillation technique, respectively.
Results: Exposure to  FiO2 of 0.8 and 1.0 resulted in significantly lower body weights and elevated coefficients of 
lung tissue damping (G) and elastance (H) when compared with controls. Hysteresivity (η) was lower due to a more 
pronounced increase of H when compared with G. A positive structure–function relation was demonstrated between 
H and the lung parenchymal content of α-smooth muscle actin (α-SMA) under hyperoxic conditions. Moreover, histol-
ogy and morphometric analyses revealed alveolar simplification, fewer pulmonary arterioles, increased α-SMA con-
tent in pulmonary vessels, and right heart hypertrophy following hyperoxia. Also, in comparison to controls, hyperoxia 
resulted in significantly lower plasma levels of vascular endothelial growth factor (VEGF). Lastly, rats in hyperoxia 
showed hyperactive and a more explorative behaviour.
Conclusions: Our in vivo infant rat model mimics clinical key features of BPD. To the best of our knowledge, this is 
the first BPD rat model demonstrating an association between lung structure and function. Moreover, we provide 
additional evidence that infant rats subjected to hyperoxia develop rarefaction of pulmonary vessels, augmented 
vascular α-SMA, and adaptive cardiac hypertrophy. Thus, our model provides a clinically relevant tool to further inves-
tigate diseases related to  O2 toxicity and to evaluate novel pharmacological treatment strategies.
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Background
Administration of supplemental oxygen  (O2) is a corner-
stone in the treatment of hypoxaemic critically ill infants 
and children. In fact, hypoxaemia is a dangerous condi-
tion that might end in persistent organ damage and neu-
rological sequelae. While hypoxaemia is feared and well 
known, noxious effects of excessive  O2 therapy are gener-
ally less recognised [1]. Neonatologists are familiar with 
clinical consequences of disproportionate  O2 adminis-
tration and challenged by bronchopulmonary dysplasia 
(BPD), a multifactorial chronic lung disease that mainly 
occurs in premature infants requiring mechanical ven-
tilation and  O2 therapy [2]. Moreover, BPD is strongly 
associated with non-favourable long-term cardiovascu-
lar and neurological disorders [3–6]. In contrast, pae-
diatric and adult intensivists maintain a rather liberal 
attitude towards  O2 therapy despite increasing evidence 
of harmful systemic effects of hyperoxia in nonhypoxae-
mic critically ill patients [7]. The current liberal practice 
is concerning since hyperoxia leads to non-physiologic 
states favouring oxidative stress [8].
Although experimental BPD models allowed invasive 
studies that cannot be performed in nonhypoxaemic 
humans, their translational potential has not been fully 
explored. Over the last decade, researchers established 
a variety of animal models to study a broad range of  O2 
concentrations applied over several days. Rats seem to be 
well suited to model developmental changes encountered 
in human lungs [9–11]. In particular, infant rat models 
of hyperoxia closely mimic histological features of the 
disorganised lung architecture observed in human BPD 
[12]. Other advantages of using rats include their highly 
developed social behaviour and relatively large body size, 
which makes it easier to carry out behavioural experi-
ments, sampling, and surgical manipulations, respec-
tively. In addition, small animal models continue to 
provide a platform for testing both established and novel 
treatment strategies for children affected from chronic 
pulmonary and cardiovascular disease [13, 14].
Despite the above mentioned advantages of hyperoxia-
based infant rat models, we argue that their potential has 
not been maximised, yet. First, besides alveolar simpli-
fication, lung fibrosis, and pulmonary vascular remod-
elling, BPD comes clinically along with impaired 
respiratory function. However, only few experimental 
studies have systematically compared structural altera-
tions with sophisticated lung function measurements 
[15]. Second, traditional histopathologic analyses are 
prone to less standardised and randomised collection 
and interpretation of data, particularly when compared 
to the advantages of image analysis. Third, there is a lack 
of animal models focusing on extra-pulmonary sequelae 
of hyperoxia-induced tissue damage.
Hence, the primary aim of our study was to relate alve-
olar remodelling and fibrosis with respiratory function 
assessed via image analysis tools and the forced oscilla-
tion technique, respectively. We hypothesised an associa-
tion between these structural alterations and respiratory 
system mechanics. The second hypothesis was that long-
term hyperoxia results in rarefaction of pulmonary ves-
sels, augmented vascular α-SMA, and adaptive cardiac 
hypertrophy.
Methods
Animals
Pregnant Sprague Dawley (SD) dams were purchased 
from Charles Rivers Laboratories International, Inc. 
(Sulzfeld, Germany) and delivered on day 14 of preg-
nancy (E14). Since the average length of the gestation 
period in rats varies between 21 and 23 days (E21–E23), 
pregnant dams had at least 1 week of acclimatization, in 
order to reduce the stress associated with transportation, 
before the initiation of our experiments. Dams and their 
pups born in our laboratory facility on day of life (DOL) 
0 were housed in individual sealed cages (T1500 IVC) 
under 12 h light and dark cycle with ad libitum access to 
water and food, at temperatures of 22–24 °C, and humid-
ity of 30–60%. The litter size varied from 8 to 15 rat pups.
From DOL 1 to 19, dams and their pups were exposed 
in three separate and consecutive series to room air 
(0.21), and to a fraction of inspired oxygen  (FiO2) of 0.6, 
0.8, and 1.0. The hyperoxic environment was created 
by a computer-controlled  O2 system based on the soft-
ware IOX (EMKA Technologies, Paris, France). Carbon 
dioxide  (CO2) concentrations in the cages were targeted 
to be below 0.4% and controlled using gas flows of 3–5 
Standard Liter Per Minute. Flow rates in the normoxic 
cages were regulated accordingly via flow regulator Vent2 
(EMKA Technologies, Paris, France).  O2 and  CO2 con-
centrations were monitored three times per day using 
the  O2 and  CO2 Datex-Ohmeda sensor (Anandic Medi-
cal System, Switzerland). As adult rats do not tolerate 
chronic exposure of high  O2 levels, dams were rotated 
every 24  h between hyperoxic and room air conditions 
to prevent hyperoxia-associated stress and discomfort. 
The chambers were daily opened for 10 min to switch the 
dams, weigh the pups, and clean the cages.
Well-being and social interaction were assessed three 
times daily and all findings were recorded on a standard-
ised score sheet. Except for daily health checks via obser-
vation of hunched posture, piloerection, eye discharge, 
and reduced social interaction, dams and pups did not 
experience any physical manipulation until DOL 5, when 
each pup was tattooed on toes according to the univer-
sal rodent numbering system. Tattoos were performed by 
pricking the skin of a specific finger with a needle dipped 
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in ink (Aramis Laboratory Animal Microtattoo System, 
Ketchum Manufacturing, Brockville, Canada).
The method of sacrifice of the infant rats at the end 
of all experiments was maximum blood withdrawal via 
direct cardiac puncture in a separate room. After eutha-
nasia of all pups, dams were culled in a euthanasia cham-
ber via  CO2 gas exposure.
Respiratory system mechanics
On DOL 19, after brief inhalational anaesthesia with iso-
flurane, infant rats were anaesthetised with an intraperi-
toneal injection of a solution containing 75  μg/g body 
weight (BW) of ketamine and 10  μg/g BW of xylazine. 
After weighing each animal and confirmation of ade-
quate level of anaesthesia via absence of pedal withdrawal 
reflex, a tracheostomy was performed and a 10 mm poly-
ethylene cannula (ID: 0.86 mm) was inserted. Rats were 
then placed in supine position on a heating mat and con-
nected to a computer-controlled ventilator  (flexiVent®, 
Scireq, Montreal, Canada) using the following settings: 
fraction of inspired  O2  (FiO2) 0.4 and 1.0 for the nor-
moxic and hyperoxic group, respectively, respiratory rate 
(RR) 90/min, tidal volume  (VT) of 8 mL/kg, and positive 
end-expiratory pressure (PEEP) 5  cm  H2O. PEEP was 
regulated by submerging the end of the expiratory tube 
into a water column. In addition, heart rate, blood pres-
sure, and  O2 saturation  (SpO2) were monitored with a 
small animal pulse oximeter (MouseOx™, STARR Life 
Sciences Corporation™, Oakmont, PA, USA) by placing a 
sensor on the proximal part of the thigh.
Next, lung volume history was standardised within 
5  min by two lung volume recruitment manoeuvers 
from 5 cm  H2O to 40 cm  H2O with 9 s ramp and 3 s pla-
teau. Then, baseline measurement of respiratory system 
input impedance  (Zrs) was performed using the low-fre-
quency forced oscillation technique (FOT) provided by 
the  flexiVent® system.  Zrs was obtained with a 6 s oscil-
lation signal of 17 mutually prime frequencies from 0.5 
to 19.75  Hz applied to the airway of the infant rat with 
a PEEP of 5 cm  H2O to prevent lung derecruitment dur-
ing  Zrs measurements. Thus, oscillations were delivered 
on top of these PEEP levels. The “constant-phase” model 
was then fitted to the resulting  Zrs, allowing the estima-
tion of airway resistance  (Raw), and the coefficients of tis-
sue damping (G) and elastance (H). Values of  Raw were 
corrected for the resistance of the tracheal cannula. Lung 
tissue hysteresivity (η) was calculated as the ratio of G 
and H. After lung function assessments pups underwent 
terminal blood withdrawal and tissue sampling. Infant 
rats exposed to  FiO2 0.6 did not undergo assessment of 
respiratory system mechanics due to lack of differences 
in weight and social behaviour when compared to the 
normoxic group.
Sampling and processing of blood
Before disconnecting animals from the ventilator, par-
tial laparotomy and sternotomy were performed and 
blood was taken via direct cardiac puncture. Blood 
was collected in plastic tubes containing the antico-
agulant EDTA and kept on ice before centrifugation 
at 3000 rpm for 10 min. Plasma was frozen at − 80  °C 
for further analysis of endothelin-1 (ET-1), and vascu-
lar endothelial growth factor (VEGF) via fluorescence 
immunoassays. Since VEGF is a marker of impaired 
vascular development, we did not measure its con-
centration in the series of experiments using  FiO2 0.6 
and 0.8 where pulmonary vessels were not analysed 
histologically.
Sampling and processing of lung and heart tissues
Lungs of infant rats exposed to  FiO2 1.0 were inflated 
and fixed via tracheal instillation of 4% formalin with a 
pressure of 10 cm  H2O. Thirty minutes later, lungs and 
heart were removed en bloc from the thoracic cavity 
and stored at − 4 °C in a formalin filled container until 
histological processing. After fixation for 48  h, lungs 
and heart were trimmed, dehydrated through graded 
alcohols and routinely paraffin wax embedded. Con-
secutive sections (3–5  µm) were prepared, mounted 
on glass slides and routinely stained with haematoxylin 
and eosin (H&E), Gomori blue trichrome or subjected 
to immunohistochemical staining for the detection of 
smooth muscle and endothelial cells. Briefly, sections 
were incubated with antibodies against α-SMA (anti-
human alpha-smooth muscle actin mouse monoclonal 
antibody), and von Willebrand Factor (anti-human fac-
tor VIII-related antigen (FVIII-Rag) rabbit polyclonal 
antibody, A0082, Dako-Agilent Technologies, Den-
mark; 1:100) for 1  h at 37  °C. Afterwards, the slides 
were incubated for 30 min with a horse radish peroxi-
dase (HRP)-labelled polymer, conjugated to a secondary 
anti-mouse and anti-rabbit antibody (Dako EnvisionTM 
System, Dako-Agilent Technologies), respectively. The 
reaction was visualised using 3,3′-diaminobenzidine 
(DAB) as chromogen, followed by light counterstain 
with haematoxylin. The immunohistochemical staining 
was performed using an Autostainer (Dako Autostainer 
Universal Staining System Model LV-1, Dako-Agilent 
Technologies). In addition, heart sections were stained 
with a fluorescent wheat germ agglutinin to assess 
cardiomyocyte size. All slides were scanned using a 
digital slide scanner (NanoZoomer-XR C12000; Hama-
matsu, Japan) and histomorphometrical analysis was 
performed on the digital slides using the Visiopharm 
Integrator System (VIS, version 4.5.1.324, Visiopharm, 
Hørsholm, Denmark), unless specified otherwise.
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Lung fibrosis
Myofibroblasts, key effector cells in the development of 
fibrosis, were identified in lung sections immunostained 
for anti-α-SMA. α-SMA-positive areas were quantified in 
each animal using at least 15 fields per section. Results 
were expressed as fraction of α-SMA-positive areas nor-
malised against the total lung parenchyma excluding the 
airspace.
Histomorphometrical study of alveolar remodelling
Alveolar diameters were estimated calculating the mean 
linear intercept (chord) length (Lm), equal to the mean 
interalveolar distance, as described previously [16]. In 
each animal, 10 representative pictures were taken at 
40× magnification from the H&E-stained lung sections, 
avoiding regions with large bronchi. A grid with 11 paral-
lel lines was overlaid onto each image, and the length of 
each chord was defined by the intercept with the alveo-
lar walls. Mean Lm was calculated by dividing the total 
length of the line drawn across the lung section by the 
number of intercepts encountered.
Alveolar counts were determined via Visiopharm soft-
ware by counting the number of alveoli per field in the 
H&E-stained sections. In each animal 15 fields per sec-
tion were analysed at 40× magnification. Briefly, 15 
regions of interest (ROIs) with a size of 0.298 mm2 were 
randomly selected from the lung parenchyma in each 
animal. A threshold classification allowed to distinguish 
between alveolar lumina and alveolar wall, and to calcu-
late the alveolar count in each ROI.
Pulmonary arterial medial wall thickness and count 
of pulmonary vessels
Pulmonary arterial medial wall hypertrophy was assessed 
at 40× magnification in lung sections immunostained for 
anti-α-SMA. At least 15 ROIs with a size of 2.605 mm2, 
containing vessels with a diameter of < 100  µm, were 
randomly selected across the lung parenchyma of all ani-
mals, excluding fields containing terminal bronchioles. A 
threshold classification allowed to distinguish between 
α-SMA-positive and negative tissue. The results were 
expressed as α-SMA-positive area per cross sectional 
vessel. The number of pulmonary vessels was assessed 
in lung sections immunostained for von Willebrand Fac-
tor within the outlined ROIs. A threshold classification 
allowed to select vessels with a diameter between 30 and 
100  µm. Fields containing bronchioles were excluded 
from the analysis.
Right ventricular hypertrophy (RVH)
The thickness of the right (RV) and left (LV) ventricular 
free walls was measured in H&E-stained heart sections 
using the NDP view software (Hamamatsu Photonics), 
and the RV/LV ratio was calculated as a marker of RVH. 
As an additional marker of RVH, the cross-sectional area 
of cardiomyocytes was assessed at 40× magnification in 
heart sections stained for anti-WGA (wheat germ agglu-
tinin). A threshold classification allowed the recognition 
of WGA-stained membrane and empty sarcoplasm in at 
least 40 representative right ventricular cardiomyocytes 
with a central 4′,6-diamidino-2-phenylindole (DAPI)-
stained nucleus.
Statistical analysis
Statistical comparisons between the normoxic and hyper-
oxic group were performed using the t-test. Where sat-
isfaction of normality and equality was not possible the 
non-parametric Mann–Whitney rank sum test was used. 
Values are reported as mean ± standard deviation for 
body weight, and as mean ± standard error of means for 
all other experimental data. Linear regression was used 
to examine the association between histological param-
eters and lung function. The strength of association was 
expressed as a coefficient of determination, denoted as  r2. 
Statistically significant data are additionally expressed as 
vertical box plots with median, 10th, 25th, 75th, and 90th 
percentiles. Statistical significance was set at a p-value 
(p) < 0.05.
Results
Social behaviour, well‑being, and survival rates
No signs of stress or abnormal behaviour were observed 
after exposure to  FiO2 0.6 and 0.8. In contrast, all infant 
rats exposed to  FiO2 1.0 developed a hyperactive behav-
iour from DOL 15 onwards. This behaviour was char-
acterised by a pronounced exploration and interaction 
without signs of self-inflicted injuries or aggression 
towards littermates. There were no deaths.
Postnatal growth
Exposure to  FiO2 0.6 did not affect weight gain in 
the hyperoxic group compared to normoxic controls 
(p = 0.645). In contrast, application of  FiO2 0.8 resulted 
in a significant weight difference on DOL 19 with nor-
moxic (n = 15) and hyperoxic (n = 14) animals weigh-
ing 39.1 ± 8  g and 36.1 ± 8  g, respectively (p = 0.041). 
A higher difference in weight was found in the  FiO2 1.0 
series with normoxic (n = 8) and hyperoxic (n = 8) infant 
rats weighing 42.9 ± 1.9  g and 38.0 ± 3.1  g, respectively 
(p < 0.001) (Fig. 1).
Respiratory system mechanics
A significantly higher airway resistance  Raw was found in 
rats exposed to  FiO2 0.8 when compared to the control 
group (0.10 ± 0.01  cm  H2O  s/mL versus 0.06 ± 0.01  cm 
 H2O  s/mL) (p = 0.002). In contrast, exposure to  FiO2 
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1.0 resulted in significantly lower  Raw (0.09 ± 0.01  cm 
 H2O  s/mL) in comparison with the normoxic group 
(0.15 ± 0.01 cm  H2O s/mL) (p < 0.001) (Fig. 2).
The coefficient of tissue damping G significantly 
increased by 38% and 21% in  FiO2 0.8 and 1.0, respec-
tively, when compared to the respective normoxic groups 
(in both cases p < 0.001) (Fig.  2). A similar pattern was 
found for the coefficient of tissue elastance H, where  FiO2 
0.8 and 1.0 resulted in 64% and 30% higher H, respec-
tively, when compared to the control groups (in both 
cases p < 0.001) (Fig.  2). Lung tissue hysteresivity η was 
18% and 7% lower after exposure to  FiO2 0.8 (p = 0.021) 
and 1.0 (p = 0.132), respectively, in comparison with the 
groups in normoxia.
Histology
Lung histology and morphometric analysis
In comparison with control animals held at room air 
(Fig. 3a), lung histology of rats exposed to  FiO2 1.0 was 
characterised by alveolar simplification, with fewer 
and larger alveoli (Fig.  3b). In particular, the hyper-
oxic group showed a significantly lower alveolar count 
per field (67 ± 3 vs 95 ± 3, p < 0.001) (Fig. 3c) and higher 
mean alveolar intercept (84 ± 4 vs 52 ± 1  µm, p < 0.001) 
(Fig.  3d). On the contrary, no significant differences in 
lung α-SMA content were found between normoxia 
(0.029 ± 0.006) and hyperoxia (0.041 ± 0.003) (p = 0.234) 
(Fig. 3e).
Histology of pulmonary vessels and heart
Hyperoxia led to a significantly lower count of pulmonary 
arterioles per field (3.5 ± 0.2) in comparison with the nor-
moxic group (5.9 ± 0.3) (p < 0.001) (Fig.  4a). In addition, 
we observed a significant difference in the hyperoxic 
group, when compared to normoxic controls, with regard 
to α-SMA content in the medial wall of pulmonary ves-
sels (1099 ± 46 versus 904 ± 50 µm2, p = 0.013) (Fig. 4b), 
RV/LV ratio (0.59 ± 0.05 versus 0.35 ± 0.01, p = 0.001) 
(Fig.  4c), and cross-sectional area of the right ventricu-
lar cardiomyocytes (78.9 ± 3.0  µm2 vs 55.3 ± 2.9  µm2, 
p < 0.001) (Fig. 4d).
Structure–function relation
A significant association between the content of α-SMA 
in lung parenchyma and tissue elastance H was observed 
in the hyperoxic study group  (r2 = 0.753, p = 0.025) 
(Fig. 5a). No association was found between mean linear 
intercept (Lm) and H, in both normoxia (p = 0.414) and 
hyperoxia (p = 0.268) (Fig. 5b).
Biomarkers
Biomarkers were measured at a single time point of DOL 
19.
VEGF and ET‑1 plasma concentrations
Hyperoxia resulted in significantly lower plasma levels 
of VEGF (3.7 ± 0.3 pg/mL) in comparison with the nor-
moxic group (4.8 ± 0.1  pg/mL) (p = 0.006), (Fig.  6a). No 
significant differences in ET-1 concentration were found 
between normoxia (24.5 ± 1.8  pg/mL) and hyperoxia 
(21.4 ± 2.6 pg/mL) (p = 0.417) (Fig. 6b).
Discussion
This study provides an infant rat model of hyperoxia-
induced tissue damage mimicking clinical key features 
of BPD. In line with our first hypothesis and as far as we 
know, this is the first BPD rat model demonstrating an 
association between lung structure and function using 
accurate diagnostic tools such as image analysis and 
FOT, respectively. Moreover, according to our second 
Fig. 1 Body weight gain from DOL 5 to 19. Curves with white and grey circles indicate the normoxic and  FiO2 0.6 (a),  FiO2 0.8 (b), and  FiO2 1.0 (c) 
groups, respectively. Asterisk displays a significant difference on DOL 19 between study groups, p < 0.05
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hypothesis, we reproduced pronounced rarefaction of 
pulmonary vessels, augmented vascular α-SMA, and 
adaptive cardiac hypertrophy.
Rats have a high translational value because they are 
born at a lung developmental stage (saccular stage) 
equivalent to that of an extreme premature infant and 
reliably reproduce structural changes closely mimicking 
human BPD [11, 12]. However, in our view the poten-
tial of BPD models has not been maximised, yet. In fact, 
although  O2 is the most commonly applied injurious 
stimulus for inducing pulmonary hallmark features of 
BPD [9], the use of different  O2 concentrations and time 
of exposure to reproduce key features of this disease has 
generated data difficult to compare [15].
Fig. 2 Respiratory system mechanics on DOL 19. Normoxic and hyperoxic study groups are illustrated with white and grey box plots, respectively. 
a–c, g  Raw, G, H, and η in normoxia (n = 6) and hyperoxia  (FiO2 0.8) (n = 6). d–f, h  Raw, G, H, and η in normoxia (n = 7) and hyperoxia  (FiO2 1.0) (n = 6). 
 Raw: airway resistance; G: coefficient of tissue damping; H: coefficient of tissue elastance; η: lung tissue hysteresivity. Data are expressed as vertical 
box plots with median, 10th, 25th, 75th, and 90th percentiles. Asterisk displays a significant difference between study groups, p < 0.05
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Hence, our group first designed an  O2-response study 
consisting of three separate and consecutive series where 
infant rats were exposed to  FiO2 of 0.6, 0.8, and 1.0.  FiO2 
0.6 was insufficient to induce clinically relevant morbid-
ity. On the contrary, the treatment with  FiO2 1.0 resulted 
in earlier and more pronounced lower body weights 
than  FiO2 0.8 as well as abnormal behaviour, in line with 
behavioural mice studies [17], when compared to nor-
moxic controls.
The properties of the respiratory system mechanics 
were characterised via FOT. The high  Raw after expo-
sure to  FiO2 0.8 (Fig. 2a) was in line with previous stud-
ies where hyperoxia led to remodelling of conducting 
airways and smooth muscles, and to increased airway 
hyperresponsiveness in infant and adult rodents [9, 18, 
19]. Surprisingly, exposure to  FiO2 1.0 resulted in lower 
 Raw compared to normoxic controls (Fig. 2d). Since we 
did not assess structural changes of the airways, we can 
only speculate whether stress-related glucocorticoid 
and catecholamine release [20], though not perceiv-
able by the experimenter, resulted in bronchodilation 
outweighing remodelling of the airways. On the other 
hand, a study performed in a BPD rabbit model showed 
no significant differences in  Raw between normoxic and 
hyperoxic animals questioning the airway remodelling 
hypothesis [21].
In agreement with comparable experimental studies 
[21, 22], tissue damping G and tissue elastance H showed 
significantly higher values after exposure to hyperoxia 
(Fig. 2). Since G and H exhibit inverse dependencies on 
body weight [23], we supposed that higher G and H after 
application of  FiO2 0.8 result from combined effects of 
hyperoxia and lower body weights. While G is closely 
related to tissue resistance and regional heterogeneity 
[24], common findings in BPD [2], H reflects tissue stiff-
ness and reduced compliance [25]. Although the levels of 
α-SMA were not significantly increased in hyperoxia, we 
observed a ~ 40% higher concentration of this biomarker 
in hyperoxic animals (Fig.  3e). The accumulation of 
α-SMA in lung tissue reflects the differentiation of lung 
fibroblasts into myofibroblasts [26], which play a major 
role in the pathogenesis of pulmonary fibrosis [27].
Fig. 3 Lung histology and morphometric analysis. Normoxic and hyperoxic study groups are illustrated with white and grey box plots, respectively. 
a, b Representative microscopic photographs of lung sections in normoxia (a) and hyperoxia (b). Magnification ×10. c–e Alveolar count, mean 
linear intercept, and ratio of α-SMA-positive lung tissue area/total parenchymal tissue area in normoxia (n = 8) and hyperoxia (n = 8). Data are 
expressed as vertical box plots with median, 10th, 25th, 75th, and 90th percentiles. Asterisk displays a significant change between study groups, 
p < 0.05
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Lung tissue hysteresivity (η) is defined as the energy 
dissipated (G) relative to the elastic energy stored in the 
lung (H) [28]. In case of moderate to severe heterogene-
ity, G increases proportionally more than H [29–31]. In 
contrast, lung derecruitment comes along with a propor-
tionate increase of G and H [31, 32]. Hence, η will rise 
or remain unchanged. In our study, a more pronounced 
increase of H in respect to G led to a decrease of η both 
after exposure to  FiO2 0.8 and  FiO2 1.0 (Fig. 2). This find-
ing was unexpected. In theory, a fall in η can occur when 
H rises proportionally more than G or when H decreases 
to a lesser extent compared to G. The second scenario 
can be excluded, since we did neither observe lower 
values of H nor G in hyperoxia. Hence, in our view, the 
behaviour of η predominantly reflected progressive lung 
volume derecruitment accompanied by a consecutive 
lung heterogeneity questioning the association between 
stable η and substantial derecruitment [31, 32].
Studies exploring the relationship between alterations 
in lung structure and functional impairment of respira-
tory mechanics in animal models of BPD are lacking 
[15]. Therefore, we related our histopathologic findings 
to changes in respiratory system mechanics. In contrast 
to experimental studies in emphysema rodent models 
[33, 34], our linear regression analysis did not show an 
association between Lm, the most commonly used index 
of airspace enlargement, and H (Fig.  5b). In our view, 
this finding is not surprising since BPD, as opposed to 
emphysema, cannot be considered solely an obstructive 
lung disease. In fact and consistent with the behaviour of 
Fig. 4 Histomorphometry of pulmonary vessels and heart. Normoxic and hyperoxic study groups are illustrated with white and grey box plots, 
respectively. a–d Count of pulmonary vessels (n = 8 + 8), α-SMA content in the medial wall of the pulmonary arterioles (n = 7 + 8), right-to-left 
ventricle wall thickness ratio (n = 3 + 6), cardiomyocyte cross-sectional area (n = 7 + 8) in normoxia and hyperoxia, respectively. Data are expressed 
as vertical box plots with median, 10th, 25th, 75th, and 90th percentiles. Asterisk displays a significant difference between study groups, p < 0.05
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η, a linear relationship was detected between lung paren-
chymal α-SMA content and H (Fig.  5a), mirroring both 
loss of lung volume and a significant restrictive compo-
nent in BPD.
In accordance with former rat BPD studies [35], we 
also found a significant rarefaction of pulmonary ves-
sels (Fig.  4a) and higher concentration of α-SMA in 
smooth muscle cells of the pulmonary arteriolar wall 
(Fig.  4b). Significantly higher levels of the right-to-left 
ventricle diameter ratio (Fig.  4c) and cardiomyocyte 
cross-sectional area (Fig. 4d), both markers of RVH, can 
be interpreted as a consequence of pulmonary vascular 
structural alterations leading to increased afterload, a 
common complication of BPD [6].
In agreement with comparable human BPD and animal 
studies [36, 37], we found that exposure to  FiO2 1.0 led 
to a significantly lower VEGF concentration in plasma 
(Fig.  6a). Measurement of the second biomarker ET-1, 
involved in the pathogenesis of pulmonary vascular dis-
ease [38], did not differ between hyperoxic and control 
groups (Fig.  6b). Baumann et  al. [39] found a signifi-
cant difference in a precursor of ET-1 in BPD-affected 
Fig. 5 Scatter plot of α-SMA to lung tissue ratio (a) and mean linear intercept (b) against lung tissue elastance (H). White and grey circles indicate 
the normoxic (n = 7) and  FiO2 1.0 (n = 6) groups, respectively;  r2 = coefficient of determination
Fig. 6 VEGF and ET-1 concentrations in plasma. Normoxic and hyperoxic study groups are illustrated with white and grey box plots, respectively. 
a VEGF concentration in normoxia (n = 8) and hyperoxia  (FiO2 1.0) (n = 8). b ET-1 concentration in normoxia (n = 8) and hyperoxia (n = 7). Data are 
expressed as vertical box plots with median, 10th, 25th, 75th, and 90th percentiles. Asterisk displays a significant change between study groups, 
p < 0.05
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children until 28  days of age only. However, this differ-
ence vanished at 36  weeks postmenstrual age. From a 
translational point of view, 19 days old infant rats can be 
compared to preschool children. Hence, it is not surpris-
ing that at the time where we measured ET-1 no signifi-
cant differences between study groups were observed.
This study is subject to limitations. First, although 
we inferred lung volume derecruitment from H values, 
we did not perform direct lung volume measurements. 
Second, we assumed that glucocorticoids and catecho-
lamines were released by the neuroendocrine system to 
contrast stress. However, we neither assessed the concen-
tration of stress hormones nor the airway calibre. Third, 
we did not perform standardised observational tests. In 
fact, our well-being score sheet was not designed to ade-
quately capture hyperactive and explorative behaviour. 
Last, although  O2 represents the most commonly applied 
injurious trigger for inducing key features of BPD, it has 
to be taken into account that the etiology of BPD is mul-
tifactorial. Therefore, to truly mirror the multifactorial 
clinical and genetic conditions contributing to human 
BPD, an ideal animal model would aim at combining 
multiple factors [9]. This remains a substantial limita-
tion, which can only partially be overcome by optimizing 
study methods.
Conclusions
To our knowledge, this is the first BPD rat model dem-
onstrating an association between pulmonary structural 
and functional changes using accurate diagnostic tools 
such as image analysis and FOT, respectively. Moreover, 
we provide additional evidence that infant rats subjected 
to hyperoxia develop rarefaction of pulmonary vessels, 
augmented vascular α-SMA, and adaptive cardiac hyper-
trophy. Hence, the present in vivo study provides a clini-
cally relevant model to further investigate pathogenesis 
of diseases related to  O2 toxicity and to evaluate novel 
pharmacological treatment strategies (Additional file  1: 
Figure S1).
Additional file
Additional file 1: Figure S1. ET-1 concentration in plasma. Normoxic 
and hyperoxic study groups are illustrated with white and grey box plots, 
respectively. A: ET-1 concentration in the normoxic (n = 13) and  FiO2 0.6 
groups (n = 14). B: ET-1 concentration in normoxia (n = 15) and hyperoxia 
 (FiO2 0.8) (n = 14). Data are expressed as vertical box plots with median, 
10th, 25th, 75th, and 90th percentiles.
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